Investigating non-inferiority or equivalence in time-to-event data under non-proportional hazards.

Equivalence Non-inferiority Non-proportional hazards Survival analysis Time-to-event data

Journal

Lifetime data analysis
ISSN: 1572-9249
Titre abrégé: Lifetime Data Anal
Pays: United States
ID NLM: 9516348

Informations de publication

Date de publication:
07 2023
Historique:
received: 05 03 2022
accepted: 10 01 2023
medline: 13 6 2023
pubmed: 29 1 2023
entrez: 28 1 2023
Statut: ppublish

Résumé

The classical approach to analyze time-to-event data, e.g. in clinical trials, is to fit Kaplan-Meier curves yielding the treatment effect as the hazard ratio between treatment groups. Afterwards, a log-rank test is commonly performed to investigate whether there is a difference in survival or, depending on additional covariates, a Cox proportional hazard model is used. However, in numerous trials these approaches fail due to the presence of non-proportional hazards, resulting in difficulties of interpreting the hazard ratio and a loss of power. When considering equivalence or non-inferiority trials, the commonly performed log-rank based tests are similarly affected by a violation of this assumption. Here we propose a parametric framework to assess equivalence or non-inferiority for survival data. We derive pointwise confidence bands for both, the hazard ratio and the difference of the survival curves. Further we propose a test procedure addressing non-inferiority and equivalence by directly comparing the survival functions at certain time points or over an entire range of time. Once the model's suitability is proven the method provides a noticeable power benefit, irrespectively of the shape of the hazard ratio. On the other hand, model selection should be carried out carefully as misspecification may cause type I error inflation in some situations. We investigate the robustness and demonstrate the advantages and disadvantages of the proposed methods by means of a simulation study. Finally, we demonstrate the validity of the methods by a clinical trial example.

Identifiants

pubmed: 36708450
doi: 10.1007/s10985-023-09589-5
pii: 10.1007/s10985-023-09589-5
pmc: PMC10258187
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

483-507

Informations de copyright

© 2023. The Author(s).

Références

Biometrics. 2009 Dec;65(4):1279-87
pubmed: 19210731
BMC Med Res Methodol. 2019 May 16;19(1):103
pubmed: 31096924
Epidemiology. 2010 Jan;21(1):13-5
pubmed: 20010207
Biol Blood Marrow Transplant. 2009 Jan;15(1 Suppl):120-7
pubmed: 19147090
Stat Methods Med Res. 2017 Feb;26(1):75-87
pubmed: 24925887
BMC Med Res Methodol. 2022 Jan 30;22(1):34
pubmed: 35094686
JAMA. 2017 Mar 28;317(12):1224-1233
pubmed: 28350928
Lancet. 2018 Mar 24;391(10126):1163-1173
pubmed: 29433850
Stat Med. 1993 Jul 30;12(14):1353-64
pubmed: 8210831
Stat Med. 2006 May 30;25(10):1628-38
pubmed: 16639773
Biometrics. 2010 Mar;66(1):30-8
pubmed: 19397582
J Biopharm Stat. 2021 Jan 2;31(1):79-90
pubmed: 32663108
Stat Med. 2011 Aug 30;30(19):2409-21
pubmed: 21611958
Stat Med. 2003 Jan 30;22(2):169-86
pubmed: 12520555
JAMA. 1997 Nov 5;278(17):1432-6
pubmed: 9356002
Stat Med. 2018 Feb 28;37(5):722-738
pubmed: 29181854
PLoS One. 2015 Jan 23;10(1):e0116774
pubmed: 25615624
J Clin Oncol. 2014 Aug 1;32(22):2380-5
pubmed: 24982461
Biometrics. 1993 Sep;49(3):877-81
pubmed: 8241376

Auteurs

Kathrin Möllenhoff (K)

Mathematical Institute, Heinrich Heine University, 40225, Düsseldorf, Germany. kathrin.moellenhoff@hhu.de.

Achim Tresch (A)

Institute of Medical Statistics and Computational Biology, Faculty of Medicine, University of Cologne, Cologne, Germany.
CEDAD, University of Cologne, Cologne, Germany.
Center for Data and Simulation Science, University of Cologne, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH